Cardinal Healthvs.Cencora
CAH vs COR · both in Distribution & pharmacy infrastructure, part of the Medicine, pharma & life science value chain: Wholesalers, distribution and pharmacy chains that get medicines to patients.
Cardinal Health and Cencora are similar in size by market cap; Cencora trades at the lower P/E (23.4 vs 31.4); year to date, Cardinal Health leads (+13.0% vs −6.3%).
Side by side
| CAH | COR | |
|---|---|---|
| Market cap | $53.8B | $61.3B |
| Price | $238.96 | $321.35 |
| Today | +2.9% | +1.3% |
| Return YTD | +13.0% | −6.3% |
| Return 1Y | +48.2% | +3.6% |
| Since June 26, 2026 | +0.4% | +12.3% |
| P/E | 31.4 | 23.4 |
| P/S | 0.2 | 0.2 |
| P/B | 53.9 | 20.1 |
Data as of 2026-10-08 · updates daily after U.S. close
Since June 26, 2026: the change in the closing price, from the daily closes Sectivia records itself since that date.
The two companies
Cardinal HealthCAH
Two businesses sit under one roof. One distributes medicines through the healthcare system, the other manufactures medical products and consumables, with pharmacy services alongside.
Full CAH profile →CencoraCOR
Known as AmerisourceBergen until the rebrand, Cencora distributes medicines and specialty drugs to the healthcare sector and sells services to pharmacies.
Full COR profile →More CAH & COR comparisons
Other head-to-heads in the Distribution & pharmacy infrastructure segment.